Best Practices for Managing Cognitive Dysfunction in Schizophrenia

PROGRAM DESCRIPTION The positive symptoms of schizophrenia, such as hallucinations, delusions, and aggressive symptoms, receive the most clinical attention and are the primary targets for pharmacological treatment. Unfortunately, it is ...

PROGRAM DESCRIPTION
The positive symptoms of schizophrenia, such as hallucinations, delusions, and aggressive symptoms, receive the most clinical attention and are the primary targets for pharmacological treatment. Unfortunately, it is the negative and cognitive symptoms that persist longer than positive symptoms, are more difficult to treat, and contribute to chronicity and disability.1Research has recently focused on studying negative symptoms, and nonpharmacological approaches to cognitive improvement in schizophrenia have demonstrated some positive change. However, clinicians do not focus enough on these “other” symptoms of schizophrenia or on the metabolic side effects of many medications used to treat this illness. In this CME Outfitters patient case and expert consult Q&A session, faculty go in-depth with the case study by answering questions while offering evidence, guidelines, and quality measures on the cognitive deficits in patients with schizophrenia. ____________________________________________References 1. Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS. Update on schizophrenia and bipolar disorder: focus on cariprazine. Neuropsychiatr Dis Treat. 2016;12:1837-1842.

EDUCATIONAL OBJECTIVES
At the end of this CE activity, participants should be able to:Evaluate the efficacy, safety, and tolerability profiles of recent FDA-approved agents to treat schizophreniaIncorporate the use of novel therapies into optimal treatment strategies to manage the cognitive symptoms of schizophrenia

---

Write the first review

Resource tags